scholarly article | Q13442814 |
P50 | author | Carmen Garnacho | Q39636660 |
Daniel Serrano | Q59692837 | ||
P2093 | author name string | Silvia Muro | |
Tridib Bhowmick | |||
Rishi Chadha | |||
P2860 | cites work | Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. | Q24300262 |
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease | Q24337312 | ||
Direct binding of the Na--H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation | Q28143472 | ||
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1 | Q28299810 | ||
Getting to the site of inflammation: the leukocyte adhesion cascade updated | Q29547271 | ||
Pathways of clathrin-independent endocytosis | Q29620660 | ||
Rapid transport of internalized P-selectin to late endosomes and the TGN: roles in regulating cell surface expression and recycling to secretory granules | Q30306202 | ||
Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane | Q30430289 | ||
RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration | Q30479484 | ||
17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange. | Q33231606 | ||
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers | Q33606794 | ||
Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway | Q33787801 | ||
Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair | Q33916052 | ||
Regulated secretion of conventional lysosomes | Q33960468 | ||
Secretory sphingomyelinase | Q34042910 | ||
Acid Sphingomyelinase Deficiency Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis in Mice | Q34625430 | ||
Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers | Q34690444 | ||
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis | Q34765872 | ||
Sphingomyelinase treatment induces ATP-independent endocytosis | Q36254906 | ||
Ceramide-enriched membrane domains | Q36286893 | ||
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway | Q36562936 | ||
Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression | Q36924524 | ||
Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction | Q37149419 | ||
Roles and regulation of secretory and lysosomal acid sphingomyelinase | Q37454661 | ||
Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease | Q37640501 | ||
Tumor necrosis factor-alpha induces stress fiber formation through ceramide production: role of sphingosine kinase. | Q39231741 | ||
Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease | Q39636269 | ||
Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes | Q40158216 | ||
CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion | Q40565703 | ||
A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. | Q40663560 | ||
Cross-linking of brain endothelial intercellular adhesion molecule (ICAM)-1 induces association of ICAM-1 with detergent-insoluble cytoskeletal fraction | Q40804499 | ||
Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells | Q40894631 | ||
Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. | Q40923925 | ||
VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes | Q41039630 | ||
Src phosphorylation of endothelial cell surface intercellular adhesion molecule-1 mediates neutrophil adhesion and contributes to the mechanism of lung inflammation | Q42148221 | ||
Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling | Q42450640 | ||
Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells | Q43737317 | ||
Membrane ruffling and macropinocytosis in A431 cells require cholesterol | Q44040005 | ||
Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke | Q44071784 | ||
Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. | Q46027250 | ||
Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins | Q46813262 | ||
ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. | Q51616072 | ||
Endocytosis pathways in endothelium: how many? | Q57374695 | ||
Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells | Q57374760 | ||
Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain | Q58023267 | ||
Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers | Q59235035 | ||
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants | Q73707747 | ||
Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane | Q77710438 | ||
Visualization of actin dynamics during macropinocytosis and exocytosis | Q77748464 | ||
Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner | Q77829347 | ||
ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface | Q78806398 | ||
Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration | Q79287551 | ||
Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis | Q81193915 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
ceramides | Q424213 | ||
P304 | page(s) | 1178-1185 | |
P577 | publication date | 2012-02-09 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium | |
P478 | volume | 32 |
Q41829569 | A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders |
Q37416891 | Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. |
Q92144962 | Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery |
Q41035019 | Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery |
Q37514889 | Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting |
Q37051502 | Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo |
Q47782730 | Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance |
Q36565901 | Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor |
Q34631547 | Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery |
Q28546649 | Dynamics of receptor-mediated nanoparticle internalization into endothelial cells |
Q38824421 | Endocytosis in gene therapy with non-viral vectors |
Q34324055 | Endothelial Na+/H+ exchanger NHE1 participates in redox-sensitive leukocyte recruitment triggered by methylglyoxal |
Q50948507 | Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice. |
Q57486638 | Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function |
Q38875899 | Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. |
Q58095621 | HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation |
Q47276739 | How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers. |
Q48736822 | ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement |
Q50887651 | ICAM-1-Targeted Nanocarriers Attenuate Endothelial Release of Soluble ICAM-1, an Inflammatory Regulator. |
Q24618791 | Intercellular adhesion molecules (ICAMs) and spermatogenesis |
Q38836304 | Intra- and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules |
Q38684097 | Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives |
Q34072528 | Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease. |
Q39021929 | Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier |
Q37574812 | Sphingolipid Organization in the Plasma Membrane and the Mechanisms That Influence It |
Q37672410 | Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders |
Q38598987 | Targeted endothelial nanomedicine for common acute pathological conditions |
Q38757789 | Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis |
Q38947567 | Targeting, endocytosis, and lysosomal delivery of active enzymes to model human neurons by ICAM-1-targeted nanocarriers. |
Q47675852 | The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series). |
Q42450605 | Trk receptors need neutral sphingomyelinase activity to promote cell viability |
Q27026630 | Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm |
Q92124409 | δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction? |